ClinVar Miner

Submissions for variant GRCh38/hg38 14q12(chr14:28766690-29666306)x1

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV003327638 SCV004034174 pathogenic Rett syndrome, congenital variant 2023-08-24 criteria provided, single submitter research A confirmed de novo heterozygous deletion of 2 genes was identified by exome sequencing in one individual with Rett syndrome ([GRCh 38] chr14:28766690_29666306x1). These breakpoints have been estimated by exome sequencing only and therefore may not reflect the true breakpoints. The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. There is complete overlap with the FOXG1 gene, which is known to be haploinsufficient and has been assessed by the ClinGen Dosage Sensitivity Working Group (https://search.clinicalgenome.org/kb/gene-dosage). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Rett syndrome. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 1 points, 3: 0 points, 4-5: 0.15 points Total: 1.15 points; Riggs 2020 (PMID: 31690835).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.